JMP Securities Maintains Jasper Therapeutics(JSPR.US) With Buy Rating, Maintains Target Price $70
Jasper Therapeutics Positioned for Success in Urticaria Market With Upcoming Briquilimab Data
3 Best Stocks to Buy Now, 1/3/2025, According to Top Analysts
Analysts Are Bullish on These Healthcare Stocks: Jasper Therapeutics (JSPR), Celldex (CLDX)
Jasper Launches AI Studio, Empowering Enterprise Marketing Teams to Build & Scale Generative AI Solutions
Insider Sale: Chief Operating Officer of $JSPR (JSPR) Sells 900 Shares
